AbbVie (ABBV) – Introduction and background |
Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.
AbbVie is an American pharmaceutical company, headquartered in Illinois.
Widgets supplied in partnership with Acuity. Pricing and sentiment does not represent ADSS data or market view.
Formerly part of Abbott Laboratories, AbbVie began life as the drug research and development department of the larger healthcare group before spinning off in 2011. One of the largest global drug developers, AbbVie has patents for top-selling drugs including Botox, Imbruvica and arthritis-treatment Rinvoq. The company’s drug portfolio spans immunology, oncology, neuroscience and aesthetics, with immunology responsible for the lion’s share of annual revenue.
AbbVie is a constituent stock of the S&P500 and S&P100 indices, and since its January 2013 IPO, has attracted major institutional investors. The largest individual stockholders are Vanguard, Blackrock and State Street.
Enjoy highly competitive CFD pricing across global markets.
Trade CFDs globally and locally across asset classes.
Benefit from using our comprehensive and customisable trading platform.